Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: Clinical Trials News
Get the latest updates from Business Wire Health: Clinical Trials News directly as they happen.
Follow now 106 followers
Latest posts
Last updated about 23 hours ago
Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
about 23 hours ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to...
Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
1 day ago
ATLANTA--(BUSINESS WIRE)--Strata Mental Health Solutions, the expert-led training and implementation partner preparing...
Owkin s’apprête à concéder une licence à Servier pour l’utilisation de K Pro et de données multimodales afin de faire progresser la recherche en oncologie
1 day ago
NEW YORK et PARIS--(BUSINESS WIRE)--Owkin, la société spécialisée dans l’IA agentique à...
Samenvatting: Owkin verleent Servier een licentie voor K Pro en multimodale gegevens om het onderzoek op het gebied van oncologie te bevorderen
1 day ago
NEW YORK & PARIJS--(BUSINESS WIRE)--Owkin, het bedrijf op het gebied van agentic...
Owkin vergibt Lizenz für K Pro und multimodale Daten an Servier zur Förderung der onkologischen Forschung
1 day ago
NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, das Unternehmen für agentenbasierte KI, das Pionierarbeit...
Riassunto: Owkin concede in licenza K Pro e dati multimodali a Servier per il progresso della ricerca oncologica
1 day ago
NEW YORK e PARIGI--(BUSINESS WIRE)--Owkin, azienda di AI agentica che ha creato...
Resumen: Owkin concederá una licencia de K Pro y datos multimodales a Servier para impulsar la investigación oncológica
1 day ago
NUEVA YORK Y PARÍS--(BUSINESS WIRE)--Owkin, empresa de inteligencia artificial agentiva pionera en...
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for Mucopolysaccharidosis Type IIIB
1 day ago
TOKYO & HYOGO, Japan--(BUSINESS WIRE)--JCR and MEDIPAL announced that the first participant...
OpenEvidence and MINC#NIMC Partner to Ensure Free Access for Canadian Physicians to Leading Medical AI Platform
1 day ago
MIAMI & OTTAWA, Ontario--(BUSINESS WIRE)-- #Canada--OpenEvidence and the Medical Identification Number for...
Aptar Pharma Expands Preservative Free Technology Production in Latin America
1 day ago
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma expands Advanced Preservative Free pump production to...
Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
1 day ago
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”)...
Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research
1 day ago
NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, the agentic AI company pioneering the first...